93 results
Page 4 of 5
424B5
eu5rzw7 d7f
28 Jul 20
Prospectus supplement for primary offering
4:17pm
424B5
tfx4 p5lw4me71d00pj
17 Apr 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
pay4c0nh36lc5p3j 05
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
424B5
tn1qk1j0zs1n4dg
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
dwe170fb6rf7 j669mm
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
424B5
yzf4e
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
EX-31.1
i96q8wcg78y
16 Mar 20
Annual report
11:09am
10-K
EX-31.2
ool9hybvu08cpwf
16 Mar 20
Annual report
11:09am
10-K
yzg1c
16 Mar 20
Annual report
11:09am
10-K
EX-31.3
49r56ar8
16 Mar 20
Annual report
11:09am
DEF 14A
i74vqv3
1 Oct 19
Definitive proxy
6:07am
8-K
EX-1.1
dosapyds
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
0tm mrjzeaocqz8fuq
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm